ROLE OF CYCLIN D1 IN THE MECHANISMS OF TAMOXIFEN RESISTANCE

Hormone-receptor positive breast cancer is the most common molecular subtype and represents 60–75 % of all breast cancers (BC). The presence of specific molecular targets such as the estrogen/progesterone receptor determines the use of hormone therapy for patients with this subtype. Tamoxifen, a sel...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: D. B. Erdyneeva, N. N. Babyshkina, T. A. Dronova, S. V. Vtorushin, E. M. Slonimskaya, V. N. Stegniy, N. V. Cherdyntseva
Format: Artigo
Idioma:Russo
Publicat: Tomsk National Research Medical Center of the Russian Academy of Sciences 2020-09-01
Col·lecció:Sibirskij Onkologičeskij Žurnal
Matèries:
hormone-receptor positive breast cancer
cyclin d1
tamoxifen
resistance mechanisms
Accés en línia:https://www.siboncoj.ru/jour/article/view/1540
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars